Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 172.2 | 147.6 | 171.5 | 247.7 | 274.7 | 226.5 |
| Revenue growth | 16.6% | -13.9% | -30.8% | -9.8% | 21.3% | |
| Cost of goods sold | 144.0 | 124.1 | 118.2 | 161.3 | 167.7 | 141.1 |
| Gross profit | 28.2 | 23.5 | 53.3 | 86.4 | 107.0 | 85.5 |
| Gross margin | 16.4% | 15.9% | 31.1% | 34.9% | 39.0% | 37.7% |
| Sales and marketing | 27.0 | 31.0 | 28.0 | 33.9 | 40.6 | 46.2 |
| Research and development | | | | 7.8 | 4.2 | 6.3 |
| General and administrative | | | | 27.6 | 28.7 | 28.4 |
| EBIT | -52.8 | -45.8 | 2.9 | 2.1 | 21.8 | -5.4 |
| EBIT margin | -30.6% | -31.0% | 1.7% | 0.9% | 7.9% | -2.4% |
| Pre-tax income | -54.9 | -53.9 | -9.2 | -3.4 | 8.8 | -7.3 |
| Income taxes | 0.0 | -0.2 | 2.1 | 1.0 | 3.3 | 0.5 |
| Tax rate | | 0.4% | | | 37.1% | |
| Net income | -55.0 | -53.7 | -11.3 | -4.4 | 5.6 | -7.7 |
| Net margin | -31.9% | -36.4% | -6.6% | -1.8% | 2.0% | -3.4% |
| |
| Diluted EPS | ($0.63) | ($0.63) | ($0.13) | ($0.05) | $0.07 | ($0.09) |
| Shares outstanding (diluted) | 87.7 | 85.0 | 84.7 | 84.7 | 85.0 | 84.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|